1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Multiomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Multiomics Market, by Products
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast
8.1.3. Software
8.1.3.1. Market Revenue and Forecast
8.1.4. Services
8.1.4.1. Market Revenue and Forecast
9.1. Multiomics Market, by Platform
9.1.1. Genomics
9.1.1.1. Market Revenue and Forecast
9.1.2. Transcriptomics
9.1.2.1. Market Revenue and Forecast
9.1.3. Proteomics
9.1.3.1. Market Revenue and Forecast
9.1.4. Metabolomics
9.1.4.1. Market Revenue and Forecast
10.1. Multiomics Market, by Application
10.1.1. Application
10.1.1.1. Market Revenue and Forecast
10.1.2. Neurology
10.1.2.1. Market Revenue and Forecast
10.1.3. Neurology
10.1.3.1. Market Revenue and Forecast
10.1.4. Cell Biology
10.1.4.1. Market Revenue and Forecast
11.1. Multiomics Market, by End User
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Academic & Research Institutes
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1. Multiomics Market, by Type
12.1.1. Single-cell Multiomics
12.1.1.1. Market Revenue and Forecast
12.1.2. Bulk Multiomics
12.1.2.1. Market Revenue and Forecast
13.1. Multiomics Market, by Technology
13.1.1. Next-Generation Sequencing (NGS)
13.1.1.1. Market Revenue and Forecast
13.1.2. Mass Spectrometry (MS)
13.1.2.1. Market Revenue and Forecast
13.1.3. PCR & Microarrays
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Products
14.1.2. Market Revenue and Forecast, by Platform
14.1.3. Market Revenue and Forecast, by Application
14.1.4. Market Revenue and Forecast, by End User
14.1.5. Market Revenue and Forecast, by Type
14.1.6. Market Revenue and Forecast, by Technology
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Products
14.1.7.2. Market Revenue and Forecast, by Platform
14.1.7.3. Market Revenue and Forecast, by Application
14.1.7.4. Market Revenue and Forecast, by End User
14.1.8. Market Revenue and Forecast, by Type
14.1.8.1. Market Revenue and Forecast, by Technology
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Products
14.1.9.2. Market Revenue and Forecast, by Platform
14.1.9.3. Market Revenue and Forecast, by Application
14.1.9.4. Market Revenue and Forecast, by End User
14.1.10. Market Revenue and Forecast, by Type
14.1.11. Market Revenue and Forecast, by Technology
14.2. Europe
14.2.1. Market Revenue and Forecast, by Products
14.2.2. Market Revenue and Forecast, by Platform
14.2.3. Market Revenue and Forecast, by Application
14.2.4. Market Revenue and Forecast, by End User
14.2.5. Market Revenue and Forecast, by Type
14.2.6. Market Revenue and Forecast, by Technology
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Products
14.2.8.2. Market Revenue and Forecast, by Platform
14.2.8.3. Market Revenue and Forecast, by Application
14.2.9. Market Revenue and Forecast, by End User
14.2.10. Market Revenue and Forecast, by Type
14.2.10.1. Market Revenue and Forecast, by Technology
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Products
14.2.11.2. Market Revenue and Forecast, by Platform
14.2.11.3. Market Revenue and Forecast, by Application
14.2.12. Market Revenue and Forecast, by End User
14.2.13. Market Revenue and Forecast, by Type
14.2.14. Market Revenue and Forecast, by Technology
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Products
14.2.15.2. Market Revenue and Forecast, by Platform
14.2.15.3. Market Revenue and Forecast, by Application
14.2.15.4. Market Revenue and Forecast, by End User
14.2.16. Market Revenue and Forecast, by Type
14.2.16.1. Market Revenue and Forecast, by Technology
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Products
14.2.17.2. Market Revenue and Forecast, by Platform
14.2.17.3. Market Revenue and Forecast, by Application
14.2.17.4. Market Revenue and Forecast, by End User
14.2.18. Market Revenue and Forecast, by Type
14.2.18.1. Market Revenue and Forecast, by Technology
14.3. APAC
14.3.1. Market Revenue and Forecast, by Products
14.3.2. Market Revenue and Forecast, by Platform
14.3.3. Market Revenue and Forecast, by Application
14.3.4. Market Revenue and Forecast, by End User
14.3.5. Market Revenue and Forecast, by Type
14.3.6. Market Revenue and Forecast, by Technology
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Products
14.3.7.2. Market Revenue and Forecast, by Platform
14.3.7.3. Market Revenue and Forecast, by Application
14.3.7.4. Market Revenue and Forecast, by End User
14.3.8. Market Revenue and Forecast, by Type
14.3.9. Market Revenue and Forecast, by Technology
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Products
14.3.10.2. Market Revenue and Forecast, by Platform
14.3.10.3. Market Revenue and Forecast, by Application
14.3.10.4. Market Revenue and Forecast, by End User
14.3.11. Market Revenue and Forecast, by Type
14.3.11.1. Market Revenue and Forecast, by Technology
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Products
14.3.12.2. Market Revenue and Forecast, by Platform
14.3.12.3. Market Revenue and Forecast, by Application
14.3.12.4. Market Revenue and Forecast, by End User
14.3.12.5. Market Revenue and Forecast, by Type
14.3.12.6. Market Revenue and Forecast, by Technology
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Products
14.3.13.2. Market Revenue and Forecast, by Platform
14.3.13.3. Market Revenue and Forecast, by Application
14.3.13.4. Market Revenue and Forecast, by End User
14.3.13.5. Market Revenue and Forecast, by Type
14.3.13.6. Market Revenue and Forecast, by Technology
14.4. MEA
14.4.1. Market Revenue and Forecast, by Products
14.4.2. Market Revenue and Forecast, by Platform
14.4.3. Market Revenue and Forecast, by Application
14.4.4. Market Revenue and Forecast, by End User
14.4.5. Market Revenue and Forecast, by Type
14.4.6. Market Revenue and Forecast, by Technology
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Products
14.4.7.2. Market Revenue and Forecast, by Platform
14.4.7.3. Market Revenue and Forecast, by Application
14.4.7.4. Market Revenue and Forecast, by End User
14.4.8. Market Revenue and Forecast, by Type
14.4.9. Market Revenue and Forecast, by Technology
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Products
14.4.10.2. Market Revenue and Forecast, by Platform
14.4.10.3. Market Revenue and Forecast, by Application
14.4.10.4. Market Revenue and Forecast, by End User
14.4.11. Market Revenue and Forecast, by Type
14.4.12. Market Revenue and Forecast, by Technology
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Products
14.4.13.2. Market Revenue and Forecast, by Platform
14.4.13.3. Market Revenue and Forecast, by Application
14.4.13.4. Market Revenue and Forecast, by End User
14.4.13.5. Market Revenue and Forecast, by Type
14.4.13.6. Market Revenue and Forecast, by Technology
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Products
14.4.14.2. Market Revenue and Forecast, by Platform
14.4.14.3. Market Revenue and Forecast, by Application
14.4.14.4. Market Revenue and Forecast, by End User
14.4.14.5. Market Revenue and Forecast, by Type
14.4.14.6. Market Revenue and Forecast, by Technology
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Products
14.5.2. Market Revenue and Forecast, by Platform
14.5.3. Market Revenue and Forecast, by Application
14.5.4. Market Revenue and Forecast, by End User
14.5.5. Market Revenue and Forecast, by Type
14.5.6. Market Revenue and Forecast, by Technology
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Products
14.5.7.2. Market Revenue and Forecast, by Platform
14.5.7.3. Market Revenue and Forecast, by Application
14.5.7.4. Market Revenue and Forecast, by End User
14.5.8. Market Revenue and Forecast, by Type
14.5.8.1. Market Revenue and Forecast, by Technology
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Products
14.5.9.2. Market Revenue and Forecast, by Platform
14.5.9.3. Market Revenue and Forecast, by Application
14.5.9.4. Market Revenue and Forecast, by End User
14.5.9.5. Market Revenue and Forecast, by Type
14.5.9.6. Market Revenue and Forecast, by Technology
15.1. Thermo Fisher Scientific
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Illumina, Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Agilent Technologies
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. QIAGEN
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Bruker Corporation
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. BGI Genomics
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. PerkinElmer (now part of Revvity)
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Waters Corporation
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Bio-Rad Laboratories
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. 10x Genomics
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client